Literature DB >> 8796401

Acute poisoning with amphetamines (MDEA) and heroin: antagonistic effects between the two drugs.

P G Jorens1, L Heytens, H E Demey, S Andries, G A Ricaurte, L Bossaert, P J Schepens.   

Abstract

A case of oral ingestion of large doses of both the amphetamine-derivative 3,4-methylene dioxyethamphetamine (MDEA) and heroin is reported. Despite high serum levels of both drugs, the patient did not present with the classic signs and symptoms normally seen during intoxication with these drugs. The patient recovered after symptomatic treatment. The possibility that opposite pharmacological properties of the two drugs prevented the patients death is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8796401     DOI: 10.1007/bf01712166

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

Review 1.  The 1988 Merck Frosst Award. The role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies.

Authors:  J Sawynok
Journal:  Can J Physiol Pharmacol       Date:  1989-09       Impact factor: 2.273

Review 2.  Regulatory proteins in presynaptic function.

Authors:  G Hertting; S Wurster; C Allgaier
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

3.  Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.

Authors:  L H Price; G A Ricaurte; J H Krystal; G R Heninger
Journal:  Arch Gen Psychiatry       Date:  1989-01

4.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

Authors:  J A Henry; K J Jeffreys; S Dawling
Journal:  Lancet       Date:  1992-08-15       Impact factor: 79.321

5.  'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA.

Authors:  G P Dowling; E T McDonough; R O Bost
Journal:  JAMA       Date:  1987-03-27       Impact factor: 56.272

6.  The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.

Authors:  G Rudnick; S C Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

7.  5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.

Authors:  C J Schmidt; V L Taylor; G M Abbate; T R Nieduzak
Journal:  J Pharmacol Exp Ther       Date:  1991-01       Impact factor: 4.030

8.  Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

Authors:  G Ricaurte; G Bryan; L Strauss; L Seiden; C Schuster
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

9.  Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; "EVE").

Authors:  J W Boja; M D Schechter
Journal:  Pharmacol Biochem Behav       Date:  1987-10       Impact factor: 3.533

10.  Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia.

Authors:  I S Chadwick; P D Curry; A Linsley; A J Freemont; B Doran
Journal:  J R Soc Med       Date:  1991-06       Impact factor: 18.000

View more
  1 in total

1.  On acute poisoning with amphetamines.

Authors:  M J Bogusz
Journal:  Intensive Care Med       Date:  1998-02       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.